.
RITES Q4 Results: PAT rises 6.5% YoY to Rs 138 crore

RITES Q4 Results: PAT rises 6.5% YoY to Rs 138 crore

Transport infrastructure consultancy and engineering firm RITES Ltd on Thursday said its profit after tax increased by 6.5 per cent to Rs 138 crore in the January-March 2023 quarter. The company had posted a profit after tax (PAT) of Rs 130 crore in the year-ago quarter, RITES said in a statement. Operating revenue, excluding other [...]
Not in any talks to acquire Restaurant Brands Asia: JFL

Not in any talks to acquire Restaurant Brands Asia: JFL

Jubilant FoodWorks Ltd (JFL), the master franchisee for Domino's Pizza and Dunkin, on Thursday said it is not in the race to acquire Restaurant Brands Asia Ltd, formerly known as Burger King India Ltd. The leading Quick Service Restaurant (QSR) chain operator said it "strongly refutes" any information appearing about a deal speculating it to [...]
Markets give up intra-day gains; fall for 3rd day

Markets give up intra-day gains; fall for 3rd day

Equity benchmark indices pared their intra-day gains and ended lower on Thursday, pulled down by index majors ITC and State Bank of India after their fourth quarter earnings failed to cheer investors. After trading in the green for most part of the day, the 30-share BSE Sensex declined 128.90 points or 0.21 per cent to [...]
IndiGo back in black on robust mkt demand, revenues; posts Rs 919.2 crore profit in March quarter

IndiGo Q4 Results: Net profit at Rs 919.2 crore

InterGlobe Aviation, the parent of the country's largest airline IndiGo, on Thursday reported a net profit of Rs 919.2 crore in the three months ended March. The company had a net loss of Rs 1,681.8 crore in the year-ago period. "For the year ended March 2023, IndiGo reported a profit of Rs 26,540 million, excluding [...]
Ashish Kacholia stock zooms more than 11% in the last 5 trading sessions; Check here to know why 

Ashish Kacholia stock zooms more than 11% in the last 5 trading sessions; Check here to know why 

Ami Organics Limited is a manufacturer of specialty chemicals based in India. These specialty chemicals mainly focus on the manufacturing and development of pharma intermediates for generic & regulated Active Pharmaceutical Ingredients (APIs) as well as New Chemical Entities (NCEs).  The company has developed and commercialized more than 450 pharma intermediates across 17 therapeutic areas. [...]